The presence of anti-HMGCR antibodies, a persistent elevation of serum CK levels for several months despite discontinuation of statin use, and profound muscle weakness are characteristic of anti-HMGCR-positive IMNM, as these features are absent in patients with self-limited statin-induced myopathy or rhabdomyolysis [23]. Here, HMGCR is linked to myopathy.